Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
Clin Pharmacol
.
2020 Oct 30:12:177-178.
doi: 10.2147/CPAA.S282866.
eCollection 2020.
Authors
Jeroen J M A Hendrikx
1
2
3
,
Jos H Beijnen
1
,
Alwin D R Huitema
1
2
3
Affiliations
1
Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
2
Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
3
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
PMID:
33162757
PMCID:
PMC7610198
DOI:
10.2147/CPAA.S282866
No abstract available